Please try another search
WuXi XDC Cayman Inc., an investment holding company, operates as a contract research, development, and manufacturing organization in China, North America, Europe, and internationally. It engages in the discovery, research, development, and manufacture of antibody drug conjugates, bioconjugates, monoclonal antibody intermediates, and payload-linkers associated with bioconjugates. The company was founded in 2013 and is headquartered in Wuxi, China. WuXi XDC Cayman Inc. operates as a subsidiary of WuXi Biologics (Cayman) Inc.
Name | Age | Since | Title |
---|---|---|---|
Jingwei Zhang | 55 | 2023 | COO & Executive Director |
Hao Zhou | 48 | 2023 | Independent Non-Executive Director |
Ulf Grawunder | 58 | 2023 | Independent Non-Executive Director |
Ming Shi | 50 | 2023 | Non-Executive Director |
Stewart John Hen | 57 | 2023 | Independent Non-Executive Director |
Are you sure you want to block %USER_NAME%?
By doing so, you and %USER_NAME% will not be able to see any of each other's Investing.com's posts.
%USER_NAME% was successfully added to your Block List
Since you’ve just unblocked this person, you must wait 48 hours before renewing the block.
I feel that this comment is:
Thank You!
Your report has been sent to our moderators for review